Ajay J Kirtane

Ajay J Kirtane is …
instance of (P31):
humanQ5

External links are
P2038ResearchGate profile IDAjay-Kirtane
P1153Scopus author ID6603083771

P108employerColumbia University Irving Medical CenterQ2415975
P106occupationresearcherQ1650915
P5008on focus list of Wikimedia projectWikiProject COVID-19Q87748614

Reverse relations

author (P50)
Q592174921003 TIMI myocardial perfusion grade predicts infarct size, perimeter and border zone following STEMI
Q432847235-year clinical outcomes after sirolimus-eluting stent implantation insights from a patient-level pooled analysis of 4 randomized trials comparing sirolimus-eluting stents with bare-metal stents
Q436108395-year results of a randomized comparison of XIENCE V everolimus-eluting and TAXUS paclitaxel-eluting stents: final results from the SPIRIT III trial (clinical evaluation of the XIENCE V everolimus eluting coronary stent system in the treatment of p
Q91034613A Need For Long-Term Results of LMCA-CTO-PCI
Q64905568A Survey of Interventional Cardiologists' Attitudes and Beliefs About Public Reporting of Percutaneous Coronary Intervention.
Q39344608A Test in Context: Fractional Flow Reserve: Accuracy, Prognostic Implications, and Limitations
Q38119880A meta-analysis of transcatheter closure of patent foramen ovale versus medical therapy for prevention of recurrent thromboembolic events in patients with cryptogenic cerebrovascular events
Q47264632A multinational clinical approach to assessing the effectiveness of catheter-based ultrasound renal denervation: The RADIANCE-HTN and REQUIRE clinical study designs
Q47100525A randomised comparison of Conventional versus Intentional straTegy in patients with high Risk prEdiction of Side branch OccLusion in coronary bifurcation interVEntion: rationale and design of the CIT-RESOLVE trial
Q44178322A randomized comparison of novel biodegradable polymer- and durable polymer-coated cobalt-chromium sirolimus-eluting stents
Q43163646A randomized comparison of the Endeavor zotarolimus-eluting stent versus the TAXUS paclitaxel-eluting stent in de novo native coronary lesions 12-month outcomes from the ENDEAVOR IV trial
Q43049810A risk score to predict bleeding in patients with acute coronary syndromes
Q57741455ACCF/SCAI/AATS/AHA/ASE/ASNC/HFSA/HRS/SCCM/SCCT/SCMR/STS 2012 appropriate use criteria for diagnostic catheterization
Q38017132ACCF/SCAI/AATS/AHA/ASE/ASNC/HFSA/HRS/SCCM/SCCT/SCMR/STS 2012 appropriate use criteria for diagnostic catheterization: American College of Cardiology Foundation Appropriate Use Criteria Task Force Society for Cardiovascular Angiography and Interventi
Q38009479ACCF/SCAI/AATS/AHA/ASE/ASNC/HFSA/HRS/SCCM/SCCT/SCMR/STS 2012 appropriate use criteria for diagnostic catheterization: a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, Society for Cardiovascular Angiograp
Q60925334APPLICATION AND OUTCOMES OF THE HYBRID APPROACH TO CHRONIC TOTAL OCCLUSION PERCUTANEOUS CORONARY INTERVENTION: AN UPDATE FROM A CONTEMPORARY MULTICENTER US REGISTRY
Q46697429Accreditation and funding for a 24-month advanced interventional cardiology fellowship program: A call-to-action for optimal training of the next generation of interventionalists
Q90759459Accuracy of Fractional Flow Reserve Derived From Coronary Angiography
Q33413684Acquired thrombocytopenia after transcatheter aortic valve replacement: clinical correlates and association with outcomes.
Q94545562Active SB-P Versus Conventional Approach to the Protection of High-Risk Side Branches: The CIT-RESOLVE Trial
Q43758526Acute left main coronary occlusion caused by stent fracture, peri-stent aneurysm formation, and very-late stent thrombosis: revisiting the dark side of drug-eluting stents
Q51253332Adherence to American College of Cardiology/American Heart Association guidelines for the management of anticoagulation in patients with mechanical valves undergoing elective outpatient procedures.
Q46822443Administration of intracoronary eptifibatide during ST-elevation myocardial infarction
Q92529195Adverse events in patients with high platelet reactivity following successful chronic total occlusion PCI: The Assessment of Dual AntiPlatelet Therapy with Drug-Eluting Stents (ADAPT-DES) study
Q85227295Age-related effects of smoking on culprit lesion plaque vulnerability as assessed by grayscale and virtual histology-intravascular ultrasound
Q93364923Algorithmic solutions to common problems encountered during chronic total occlusion angioplasty: The algorithms within the algorithm
Q91279201An Updated Healthcare System-Wide Clinical Pathway for Managing Patients With Chest Pain and Acute Coronary Syndromes
Q38962250An Updated Protocol for Evaluating Chest Pain and Managing Acute Coronary Syndromes
Q53127895An angiographic tool based on Visual estimation for Risk prEdiction of Side branch OccLusion in coronary bifurcation interVEntion: the V-RESOLVE score system.
Q51015163An angiographic tool for risk prediction of side branch occlusion in coronary bifurcation intervention: the RESOLVE score system (Risk prEdiction of Side branch OccLusion in coronary bifurcation interVEntion).
Q35787402Analysis of early out-of hospital mortality after transcatheter aortic valve implantation among patients with aortic stenosis successfully discharged from the hospital and alive at 30 days (from the placement of aortic transcatheter valves trial).
Q45238086Angiographic and clinical outcomes associated with direct versus conventional stenting among patients treated with fibrinolytic therapy for ST-elevation acute myocardial infarction
Q46475076Angiographic patterns of drug-eluting stent restenosis and one-year outcomes after treatment with repeated percutaneous coronary intervention
Q51545745Angiographic predictors of 2-year stent thrombosis in patients receiving drug-eluting stents: Insights from the ADAPT-DES study.
Q28199569Angiographically evident thrombus following fibrinolytic therapy is associated with impaired myocardial perfusion in STEMI: a CLARITY-TIMI 28 substudy
Q34487339Anticoagulant therapy during primary percutaneous coronary intervention for acute myocardial infarction: a meta-analysis of randomized trials in the era of stents and P2Y12 inhibitors
Q87943993Aortic Valve Stenosis
Q38223702Aortic stenosis and coronary artery disease: what do we know? What don't we know? A comprehensive review of the literature with proposed treatment algorithms
Q36011391Application and outcomes of a hybrid approach to chronic total occlusion percutaneous coronary intervention in a contemporary multicenter US registry.
Q96160509Approach to Acute Cardiovascular Complications in COVID-19 Infection
Q48908278Approaches to percutaneous coronary intervention of right coronary artery chronic total occlusions: insights from a multicentre US registry
Q85221556Are the current American College of Cardiology/American Heart Association stable ischemic heart disease guidelines too conservative?
Q93061032Association Between Hypertension, Platelet Reactivity, and the Risk of Adverse Events After Percutaneous Coronary Intervention (From the ADAPT-DES Study)
Q92843402Association Between Transcatheter Aortic Valve Replacement and Early Postprocedural Stroke
Q86606555Association between intraprocedural thrombotic events and adverse outcomes after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction (a Harmonizing Outcomes With RevasculariZatiON and Stents in Acute Myocardial
Q80333403Association between thrombolysis in myocardial infarction myocardial perfusion grade, biomarkers, and clinical outcomes among patients with moderate- to high-risk acute coronary syndromes: observations from the randomized trial to evaluate the relat
Q36357689Association of Patient-Reported Health Status With Long-Term Mortality After Transcatheter Aortic Valve Replacement: Report From the STS/ACC TVT Registry
Q90960309Association of Physician Variation in Use of Manual Aspiration Thrombectomy With Outcomes Following Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction: The National Cardiovascular Data Registry CathPCI Registry
Q90242440Association of Renin-Angiotensin Inhibitor Treatment With Mortality and Heart Failure Readmission in Patients With Transcatheter Aortic Valve Replacement
Q49387582Association of Stress Test Risk Classification With Health Status After Chronic Total Occlusion Angioplasty (from the Outcomes, Patient Health Status and Efficiency in Chronic Total Occlusion Hybrid Procedures [OPEN-CTO] Study).
Q40127504Association of TIMI myocardial perfusion grade and ST-segment resolution with cardiovascular magnetic resonance measures of microvascular obstruction and infarct size following ST-segment elevation myocardial infarction
Q38377257Association of Transcatheter Aortic Valve Replacement With 30-Day Renal Function and 1-Year Outcomes Among Patients Presenting With Compromised Baseline Renal Function: Experience From the PARTNER 1 Trial and Registry
Q52675179Association of Tricuspid Regurgitation With Transcatheter Aortic Valve Replacement Outcomes: A Report From The Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry.
Q42646459Association of a negative residual stenosis following rescue/adjunctive percutaneous coronary intervention with impaired myocardial perfusion and adverse outcomes among ST-segment elevation myocardial infarction patients
Q46780330Association of blood glucose with angiographic and clinical outcomes among patients with ST-segment elevation myocardial infarction (from the CLARITY-TIMI-28 study).
Q81319198Association of culprit lesion calcium with angiographic and clinical outcomes in patients with ST-elevation myocardial infarction treated with fibrinolytic therapy
Q80507974Association of duration of symptoms at presentation with angiographic and clinical outcomes after fibrinolytic therapy in patients with ST-segment elevation myocardial infarction
Q80538474Association of epicardial and tissue-level reperfusion with left ventricular end-diastolic pressures in ST-elevation myocardial infarction
Q44953154Association of lesion complexity following fibrinolytic administration with mortality in ST-elevation myocardial infarction
Q53847534Association of peripheral neutrophilia with adverse angiographic outcomes in ST-elevation myocardial infarction.
Q53617022Association of platelet counts on presentation and clinical outcomes in ST-elevation myocardial infarction (from the TIMI Trials).
Q81278510Association of smoking with improved myocardial perfusion and the angiographic characterization of myocardial tissue perfusion after fibrinolytic therapy for ST-segment elevation myocardial infarction
Q52010089Association of the Fibonacci Cascade with the distribution of coronary artery lesions responsible for ST-segment elevation myocardial infarction.
Q34974622Associations of major bleeding and myocardial infarction with the incidence and timing of mortality in patients presenting with non-ST-elevation acute coronary syndromes: a risk model from the ACUITY trial
Q37034829Balancing efficacy and safety of drug-eluting stents in patients undergoing percutaneous coronary intervention
Q44352059Benefit of transferring ST-segment-elevation myocardial infarction patients for percutaneous coronary intervention compared with administration of onsite fibrinolytic declines as delays increase
Q80057720Benefits of achieving the NCEP optional LDL-C goal among elderly patients with ACS
Q53522097Bilateral embolic protection devices for high-risk cardiac surgery in a patient with recent embolic stroke.
Q28281179Bivalirudin during primary PCI in acute myocardial infarction
Q41716870Bivalirudin is associated with improved clinical and economic outcomes in heart failure patients undergoing percutaneous coronary intervention: Results from an observational database
Q39388995Bleeding Events Before Coronary Angiography in Patients With Non-ST-Segment Elevation Acute Coronary Syndrome
Q88995368Bleeding Severity After Percutaneous Coronary Intervention
Q35610354Bleeding and stent thrombosis on P2Y12-inhibitors: collaborative analysis on the role of platelet reactivity for risk stratification after percutaneous coronary intervention
Q44068164Bleeding complications after surgical aortic valve replacement compared with transcatheter aortic valve replacement: insights from the PARTNER I Trial (Placement of Aortic Transcatheter Valve).
Q91675288Burden of Valvular Heart Diseases in Hispanic/Latino Individuals in the United States: The Echocardiographic Study of Latinos
Q81123146C-reactive protein and cardiovascular outcomes in smokers versus nonsmokers in non-ST-elevation acute coronary syndrome (from the TACTICS-TIMI 18 trial)
Q81562997CABG surgery versus drug-eluting stent implantation in multivessel disease: an interventional cardiology perspective
Q51191415CASE 11-2016 Perioperative Coronary Thrombosis in a Patient With Multiple Second-Generation Drug-Eluting Stents: Is It Time for a Paradigm Shift?
Q38380438COCATS 4 Task Force 13: Training in Critical Care Cardiology
Q82491369Cardiac allograft vasculopathy
Q91847324Cardiac allograft vasculopathy: A review
Q90575837Cardiovascular Considerations for Patients, Health Care Workers, and Health Systems During the Coronavirus Disease 2019 (COVID-19) Pandemic
Q90566922Catheterization Laboratory Considerations During the Coronavirus (COVID-19) Pandemic: From ACC's Interventional Council and SCAI
Q93135752Changes in 24-Hour Patterns of Blood Pressure in Hypertension Following Renal Denervation Therapy
Q43759546Changes in reference vessel diameter in ST-segment elevation myocardial infarction after primary percutaneous coronary intervention: implications for appropriate stent sizing
Q87613932Characteristics of early versus late in-stent restenosis in second-generation drug-eluting stents: an optical coherence tomography study
Q47597302Characterization of the Average Daily Ischemic and Bleeding Risk After Primary PCI for STEMI.
Q43607711Clearing the air on the "smoker's paradox".
Q57741465Clinical Outcomes Using a New Crossover Balloon Occlusion Technique for Percutaneous Closure After Transfemoral Aortic Valve Implantation
Q94479215Clinical Pathway for Management of Suspected or Positive Novel Coronavirus-19 Patients With ST-Segment Elevation Myocardial Infarction
Q43256615Clinical and angiographic outcomes in diabetics from the ENDEAVOR IV trial: randomized comparison of zotarolimus- and paclitaxel-eluting stents in patients with coronary artery disease
Q52573656Clinical and hemodynamic effects of intra-aortic balloon pump therapy in chronic heart failure patients with cardiogenic shock.
Q46834205Clinical outcomes after heterogeneous overlap stenting with drug-eluting stents and bare-metal stents for de novo coronary artery narrowings
Q39629315Clinical outcomes after transcatheter aortic valve replacement using valve academic research consortium definitions: a weighted meta-analysis of 3,519 patients from 16 studies
Q56977791Clinical outcomes with drug-eluting and bare-metal stents in patients with ST-segment elevation myocardial infarction: evidence from a comprehensive network meta-analysis
Q39117693Clinical profile and impact of family history of premature coronary artery disease on clinical outcomes of patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction: analysis from the HORIZONS-AMI Trial
Q37031580Clinical use of sirolimus-eluting stents
Q46678659Clinical, procedural, and pharmacologic correlates of acute and subacute stent thrombosis: results of a multicenter case-control study with 145 thrombosis events
Q84700997Comparative effectiveness of revascularization strategies
Q46904308Comparative effectiveness of upstream glycoprotein IIb/IIIa inhibitors in patients with moderate- and high-risk acute coronary syndromes: an Acute Catheterization and Urgent Intervention Triage Strategy (ACUITY) substudy
Q93000698Comparison Between Traditional and Guide-Catheter Extension Reverse Controlled Antegrade Dissection and Retrograde Tracking: Insights From the PROGRESS-CTO Registry
Q92572703Comparison of Age (<75 Years Vs ≥75 Years) and Platelet Reactivity to the Risk of Thrombotic and Bleeding Events After Successful Percutaneous Coronary Intervention With Drug-Eluting Stents (from the ADAPT-DES Study)
Q42883088Comparison of Bivalirudin versus Bivalirudin plus glycoprotein IIb/IIIa inhibitor versus heparin plus glycoprotein IIb/IIIa inhibitor in patients with acute coronary syndromes having percutaneous intervention for narrowed saphenous vein aorto-corona
Q89364296Comparison of Causes and Associated Costs of 30-Day Readmission of Transcatheter Implantation Versus Surgical Aortic Valve Replacement in the United States (A National Readmission Database Study)
Q92755116Comparison of Incidence and Outcomes of Cardiogenic Shock Complicating Posterior (Inferior) Versus Anterior ST-Elevation Myocardial Infarction
Q90738813Comparison of Percutaneous and Surgical Right Ventricular Assist Device Support After Durable Left Ventricular Assist Device Insertion
Q87414258Comparison of Three-year outcomes after primary percutaneous coronary intervention in patients with left ventricular ejection fraction <40% versus ≥ 40% (from the HORIZONS-AMI trial)
Q82872483Comparison of angiographic and intravascular ultrasonic detection of myocardial bridging of the left anterior descending coronary artery
Q53582965Comparison of biodegradable polymer versus durable polymer sirolimus-eluting stenting in patients with acute st-elevation myocardial infarction undergoing primary percutaneous coronary intervention: results of the RESOLVE study.
Q34123999Comparison of catheterization laboratory initiated abciximab and eptifibatide during percutaneous coronary intervention in acute coronary syndromes (an ACUITY substudy).
Q51209249Comparison of effects of bare metal versus drug-eluting stent implantation on biomarker levels following percutaneous coronary intervention for non-ST-elevation acute coronary syndrome.
Q44571172Comparison of long-term (4-year) outcomes of patients with unprotected left main coronary artery narrowing treated with drug-eluting stents versus coronary-artery bypass grafting
Q33413571Comparison of outcomes in patients with ST-segment elevation myocardial infarction discharged on versus not on statin therapy (from the Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction Trial).
Q28252387Comparison of outcomes using sirolimus-eluting stenting in diabetic versus nondiabetic patients with comparison of insulin versus non-insulin therapy in the diabetic patients
Q53318664Comparison of plaque characteristics in narrowings with ST-elevation myocardial infarction (STEMI), non-STEMI/unstable angina pectoris and stable coronary artery disease (from the ADAPT-DES IVUS Substudy).
Q46564787Comparison of various scores for predicting success of chronic total occlusion percutaneous coronary intervention.
Q82994487Comparison of very early treatment with either fibrinolysis or percutaneous coronary intervention facilitated with abciximab with respect to ST recovery and infarct-related artery epicardial flow in patients with acute ST-segment elevation myocardia
Q92884981Competency-Based Assessment of Interventional Cardiology Fellows' Abilities in Intracoronary Physiology and Imaging
Q40364813Completeness of revascularization and its impact on the outcomes of a staged approach of percutaneous coronary intervention followed by minimally invasive valve surgery for patients with concomitant coronary artery and valvular heart disease
Q26829251Consensus and update on the definition of on-treatment platelet reactivity to adenosine diphosphate associated with ischemia and bleeding
Q41626966Contemporary Outcomes of Venoarterial Extracorporeal Membrane Oxygenation for Refractory Cardiogenic Shock at a Large Tertiary Care Center.
Q47102964Contrast Utilization During Chronic Total Occlusion Percutaneous Coronary Intervention: Insights From a Contemporary Multicenter Registry
Q92182310Conversation in cardiology: Is there a need for clinical trials for the nonhyperemic pressure ratios?
Q38886576Coronary Thrombosis and Major Bleeding After PCI With Drug-Eluting Stents: Risk Scores From PARIS.
Q37459124Coronary artery aneurysms after drug-eluting stent implantation
Q39568683Correlates and outcomes of late and very late drug-eluting stent thrombosis: results from DESERT (International Drug-Eluting Stent Event Registry of Thrombosis).
Q40917616Correlates and outcomes related to periprocedural myocardial injury during percutaneous coronary intervention for chronic total occlusion: Results from a prospective, single center PCI registry
Q38614650Correlates and prognostic impact of new-onset heart failure after ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention: insights from the INFUSE-AMI trial
Q46000220Correlates of adverse events during saphenous vein graft intervention with distal embolic protection: a PRIDE substudy.
Q79743746Correlates of bleeding events among moderate- to high-risk patients undergoing percutaneous coronary intervention and treated with eptifibatide: observations from the PROTECT-TIMI-30 trial
Q88567581Cost implications of intraprocedural thrombotic events and bleeding in percutaneous coronary intervention: Results from the CHAMPION PHOENIX ECONOMICS Study
Q41333305Cost implications of intraprocedural thrombotic events during PCI.
Q38501364Current controversies over bioresorbable scaffolds
Q92665542Derivation and external validation of a novel risk score for prediction of 30-day mortality after percutaneous coronary intervention
Q46675604Design and rationale of the ANALYZE ST study: a prospective, nonrandomized, multicenter ST monitoring study to detect acute coronary syndrome events in implantable cardioverter-defibrillator patients
Q61633802Development and Validation of a Scoring System for Predicting Periprocedural Complications During Percutaneous Coronary Interventions of Chronic Total Occlusions: The Prospective Global Registry for the Study of Chronic Total Occlusion Intervention (
Q91893651Device-based therapies for arterial hypertension
Q26739024Diagnosis and Management of Cardiovascular Disease in Advanced and End-Stage Renal Disease
Q94508941Diagnostic Performance of Angiography-based Fractional Flow Reserve in Various Subgroups: Report from the FAST-FFR Study
Q36516029Diagnostic and prognostic utility of brain natriuretic Peptide in subjects admitted to the ICU with hypoxic respiratory failure due to noncardiogenic and cardiogenic pulmonary edema
Q53419376Differences in Underlying Culprit Lesion Morphology Between Men and Women: An IVUS Analysis From the ADAPT-DES Study.
Q46733046Differential outcomes after sirolimus-eluting stent implantation: comparing on-label versus off-label patients in the 'real world'.
Q44464832Direct infusion of fenoldopam into the renal arteries to protect against contrast-induced nephropathy in patients at increased risk
Q79404162Distal embolization of thrombus in acute myocardial infarction
Q51719870Distance from the coronary ostium to the culprit lesion in acute ST-elevation myocardial infarction and its implications regarding the potential prevention of proximal plaque rupture.
Q51805744Does calcium burden impact culprit lesion morphology and clinical results? An ADAPT-DES IVUS substudy.
Q88591614EC-VAD: Combined Use of Extracorporeal Membrane Oxygenation and Percutaneous Microaxial Pump Left Ventricular Assist Device
Q57741472Early and Late (One Year) Outcomes Following Transcatheter Aortic Valve Implantation in Patients With Severe Aortic Stenosis (from the United States REVIVAL Trial)
Q80333361Early initiation of eptifibatide in the emergency department before primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: results of the Time to Integrilin Therapy in Acute Myocardial Infarction (TITAN)-TIMI 34 t
Q39540449Effect of Lesion Age on Outcomes of Chronic Total Occlusion Percutaneous Coronary Intervention: Insights From a Contemporary US Multicenter Registry
Q36739542Effect of Previous Failure on Subsequent Procedural Outcomes of Chronic Total Occlusion Percutaneous Coronary Intervention (from a Contemporary Multicenter Registry).
Q38380117Effect of Short Procedural Duration With Bivalirudin on Increased Risk of Acute Stent Thrombosis in Patients With STEMI: A Secondary Analysis of the HORIZONS-AMI Randomized Clinical Trial
Q39462063Effect of Smoking on Infarct Size and Major Adverse Cardiac Events in Patients With Large Anterior ST-Elevation Myocardial Infarction (from the INFUSE-AMI Trial).
Q91995607Effect of Smoking on Outcomes of Primary PCI in Patients With STEMI
Q38418337Effect of obesity on coronary atherosclerosis and outcomes of percutaneous coronary intervention: grayscale and virtual histology intravascular ultrasound substudy of assessment of dual antiplatelet therapy with drug-eluting stents
Q57452870Effect of orbital atherectomy in calcified coronary artery lesions as assessed by optical coherence tomography
Q47216847Effect of rescue or adjunctive percutaneous coronary intervention of the culprit artery after fibrinolytic administration on epicardial flow in nonculprit arteries
Q46711890Effectiveness of drug-eluting stent implantation for patients with unprotected left main coronary artery stenosis
Q46848569Effects of pretreatment with clopidogrel on nonemergent percutaneous coronary intervention after fibrinolytic administration for ST-segment elevation myocardial infarction: a Clopidogrel as Adjunctive Reperfusion Therapy-Thrombolysis in Myocardial I
Q88871710Endovascular ultrasound renal denervation to treat hypertension (RADIANCE-HTN SOLO): a multicentre, international, single-blind, randomised, sham-controlled trial
Q38398711Etiology, Frequency, and Clinical Outcomes of Myocardial Infarction After Successful Drug-Eluting Stent Implantation: Two-Year Follow-Up From the ADAPT-DES Study
Q79160423Evaluation of the association of proximal coronary culprit artery lesion location with clinical outcomes in acute myocardial infarction
Q93035742Factors Associated With and Outcomes of Aborted Procedures During Elective Transcatheter Aortic Valve Replacement
Q47722489Feasibility and Early Safety of Single-Stage Hybrid Coronary Intervention and Valvular Cardiac Surgery
Q51001316Feasibility of smaller arterial cannulas in venoarterial extracorporeal membrane oxygenation.
Q51058537Femoral vascular closure device use, bivalirudin anticoagulation, and bleeding after primary angioplasty for STEMI: results from the HORIZONS-AMI trial.
Q36254711First-in-Human Evaluation of a Novel Polymer-Free Drug-Filled Stent: Angiographic, IVUS, OCT, and Clinical Outcomes From the RevElution Study
Q96166228First-in-Human Study of the Saranas Early Bird Bleed Monitoring System for the Detection of Endovascular Procedure-Related Bleeding Events
Q38402937Fixed and Modifiable Correlates of Drug-Eluting Stent Thrombosis From a Large All-Comers Registry: Insights From ADAPT-DES.
Q95315231Follow-up Outcomes After Chronic Total Occlusion Percutaneous Coronary Intervention in Patients With and Without Prior Coronary Artery Bypass Graft Surgery: Insights From the PROGRESS-CTO Registry
Q91044842Frequency and Outcomes of Ad Hoc Versus Planned Chronic Total Occlusion Percutaneous Coronary Intervention: Multicenter Experience
Q43209404Frequency and clinical consequences associated with sidebranch occlusion during stent implantation using zotarolimus-eluting and paclitaxel-eluting coronary stents
Q36985650Gait speed and dependence in activities of daily living in older adults with severe aortic stenosis
Q42634785Gastrointestinal bleeding in patients with acute coronary syndromes: incidence, predictors, and clinical implications: analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial
Q46883865Gender-specific outcomes after sirolimus-eluting stent implantation
Q96291145Geographic Access to Transcatheter Aortic Valve Replacement Centers in the United States: Insights From the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry
Q46590937Guidewire and microcatheter utilization patterns during antegrade wire escalation in chronic total occlusion percutaneous coronary intervention: Insights from a contemporary multicenter registry
Q89191044Habitual Physical Activity: Functional Assessment in Patients With Severe Aortic Stenosis Treated With TAVR
Q89516509Haemodynamic support for cardiogenic shock and high-risk PCI: what can observational data tell us?
Q92014699Hemopericardium and Cardiac Tamponade as a Complication of Vena Caval Filters: Systematic Review of the Published Literature and the MAUDE Database
Q39425550Heparin Versus Bivalirudin in ST-Segment Elevation Myocardial Infarction: A SCAI-Based National Survey From US Interventional Cardiologists
Q79317346Hospital delays in reperfusion for ST-elevation myocardial infarction: implications when selecting a reperfusion strategy
Q34609578How to define a poor outcome after transcatheter aortic valve replacement: conceptual framework and empirical observations from the placement of aortic transcatheter valve (PARTNER) trial
Q37930845How to minimize stent thrombosis
Q84927508Hypothyroid cardiomyopathy: a reversible form of systolic heart failure
Q60925347IMPACT OF AGE ON OUTCOMES OF PERCUTANEOUS CORONARY INTERVENTION IN CHRONIC TOTAL OCCLUSIONS: INSIGHTS FROM A MULTICENTER US REGISTRY
Q48954077Imaging- and physiology-guided percutaneous coronary intervention without contrast administration in advanced renal failure: a feasibility, safety, and outcome study.
Q40774686Impact of Anemia on Platelet Reactivity and Ischemic and Bleeding Risk: From the Assessment of Dual Antiplatelet Therapy With Drug-Eluting Stents Study
Q45064792Impact of Aspirin and Clopidogrel Hyporesponsiveness in Patients Treated With Drug-Eluting Stents: 2-Year Results of a Prospective, Multicenter Registry Study
Q36370689Impact of Calcium on Chronic Total Occlusion Percutaneous Coronary Interventions
Q47929076Impact of Chronic Total Occlusions on Revascularization Scores and Outcome Prediction
Q34486268Impact of Contrast-Induced Acute Kidney Injury After Percutaneous Coronary Intervention on Short- and Long-Term Outcomes: Pooled Analysis From the HORIZONS-AMI and ACUITY Trials
Q46262291Impact of Hemoglobin A1c Levels on Residual Platelet Reactivity and Outcomes After Insertion of Coronary Drug-Eluting Stents (from the ADAPT-DES Study).
Q90348560Impact of Point-of-Care Platelet Function Testing Among Patients With and Without Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents (from the ADAPT-DES Study)
Q50064019Impact of Pre-Diabetes on Coronary Plaque Composition and Clinical Outcome in Patients With Acute Coronary Syndromes: An Analysis From the PROSPECT Study
Q30276003Impact of Preoperative Chronic Kidney Disease in 2,531 High-Risk and Inoperable Patients Undergoing Transcatheter Aortic Valve Replacement in the PARTNER Trial
Q51781001Impact of Proximal Cap Ambiguity on Outcomes of Chronic Total Occlusion Percutaneous Coronary Intervention: Insights From a Multicenter US Registry.
Q91040575Impact of Smoking on Platelet Reactivity and Clinical Outcomes After Percutaneous Coronary Intervention: Findings From the ADAPT-DES Study
Q93192930Impact of Subintimal or Plaque Modification on Repeat Chronic Total Occlusion Angioplasty Following an Unsuccessful Attempt
Q46478102Impact of Surgical Consultation on Outcomes in Hemodynamically Supported High-Risk Percutaneous Coronary Intervention: Insights From PROTECT II Randomized Study
Q44297604Impact of atrial fibrillation in patients with ST-elevation myocardial infarction treated with percutaneous coronary intervention (from the HORIZONS-AMI [Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction] trial).
Q43288786Impact of chronic kidney disease on early (30-day) and late (1-year) outcomes of patients with acute coronary syndromes treated with alternative antithrombotic treatment strategies: an ACUITY (Acute Catheterization and Urgent Intervention Triage str
Q53476914Impact of chronic statin therapy on clinical presentation and underlying lesion morphology in patients undergoing percutaneous intervention: an ADAPT-DES IVUS substudy.
Q91850864Impact of concomitant treatment of non-chronic total occlusion lesions at the time of chronic total occlusion intervention
Q30988733Impact of contrast agent type (ionic versus nonionic) used for coronary angiography on angiographic, electrocardiographic, and clinical outcomes following thrombolytic administration in acute myocardial infarction
Q43732977Impact of depressed left ventricular function on outcomes in patients with three-vessel coronary disease undergoing percutaneous coronary intervention.
Q57169159Impact of high on-aspirin platelet reactivity on outcomes following successful percutaneous coronary intervention with drug-eluting stents
Q91266467Impact of high on-treatment platelet reactivity on outcomes following PCI in patients on hemodialysis: An ADAPT-DES substudy
Q56334747Impact of percutaneous coronary intervention extent, complexity and platelet reactivity on outcomes after drug-eluting stent implantation
Q91228334Impact of renin-angiotensin system inhibitors on clinical outcomes in patients with severe aortic stenosis undergoing transcatheter aortic valve replacement: an analysis of from the PARTNER 2 trial and registries
Q94950351Impact of the COVID-19 pandemic on interventional cardiology fellowship training in the New York metropolitan area: A perspective from the United States epicenter
Q34637924Impact of the presence and extent of incomplete angiographic revascularization after percutaneous coronary intervention in acute coronary syndromes: the Acute Catheterization and Urgent Intervention Triage Strategy (ACUITY) trial
Q44945169Impact of the severity of coronary artery calcification on clinical events in patients undergoing coronary artery bypass grafting (from the Acute Catheterization and Urgent Intervention Triage Strategy Trial).
Q90308303Impella-assisted chronic total occlusion percutaneous coronary interventions: A multicenter retrospective analysis
Q38808379Implications of Public Reporting of Risk-Adjusted Mortality Following Percutaneous Coronary Intervention: Misperceptions and Potential Consequences for High-Risk Patients Including Nonsurgical Patients
Q38284058Important role of mechanical circulatory support in acute myocardial infarction complicated by cardiogenic shock
Q92586201Improved survival and cardiovascular outcomes with renin-angiotensin inhibitor use after transcatheter aortic valve replacement
Q91143032Improvement in left ventricular function following higher-risk percutaneous coronary intervention in patients with ischemic cardiomyopathy
Q93042499Improving Quality for All Patients With Aortic Stenosis
Q92363699In-Hospital Outcomes of Chronic Total Occlusion Percutaneous Coronary Interventions in Patients With Prior Coronary Artery Bypass Graft Surgery
Q92560283In-Stent Restenosis Lesion Morphology Related to Repeat Stenting Underexpansion as Evaluated by Optical Coherence Tomography
Q91366193In-hospital Outcomes of Attempting More Than One Chronic Total Coronary Occlusion Through Percutaneous Intervention During the Same Procedure
Q53109004Incentivizing Transradial Access for Primary Percutaneous Coronary Intervention While Maintaining Timely Reperfusion.
Q38830468Incidence and Implications of Left Ventricular Distention During Venoarterial Extracorporeal Membrane Oxygenation Support.
Q90181228Incidence and Outcomes of Surgical Bailout During TAVR: Insights From the STS/ACC TVT Registry
Q36990354Incidence and effect of acute kidney injury after transcatheter aortic valve replacement using the new valve academic research consortium criteria
Q37987647Incidence and predictors of coronary stent thrombosis: evidence from an international collaborative meta-analysis including 30 studies, 221,066 patients, and 4276 thromboses
Q91320490Incidence, Management, and Associated Clinical Outcomes of New-Onset Atrial Fibrillation Following Transcatheter Aortic Valve Replacement: An Analysis From the STS/ACC TVT Registry
Q41445718Incidence, Predictors, and Impact of Post-Discharge Bleeding After Percutaneous Coronary Intervention
Q92638865Incidence, Temporal Trends, and Associated Outcomes of Vascular and Bleeding Complications in Patients Undergoing Transfemoral Transcatheter Aortic Valve Replacement: Insights From the Society of Thoracic Surgeons/American College of Cardiology Tran
Q43562497Incidence, Treatment, and Outcomes of Coronary Perforation During Chronic Total Occlusion Percutaneous Coronary Intervention.
Q38838323Infarct size, left ventricular function, and prognosis in women compared to men after primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: results from an individual patient-level pooled analysis of 10 randomized
Q47650397Inferior Vena Cava Filters to Prevent Pulmonary Embolism: Systematic Review and Meta-Analysis
Q43500037Intra-procedural stent thrombosis: a new risk factor for adverse outcomes in patients undergoing percutaneous coronary intervention for acute coronary syndromes
Q51176352Intracoronary bolus administration of eptifibatide during percutaneous coronary stenting for non ST elevation myocardial infarction and unstable angina.
Q71185472Intrapericardial teratoma--a case report
Q34638192Intraprocedural thrombotic events during percutaneous coronary intervention in patients with non-ST-segment elevation acute coronary syndromes are associated with adverse outcomes: analysis from the ACUITY (Acute Catheterization and Urgent Intervent
Q38776391Intravascular Ultrasound Analysis of Intraplaque Versus Subintimal Tracking in Percutaneous Intervention for Coronary Chronic Total Occlusions and Association With Procedural Outcomes
Q91043254Intravascular Ultrasound Assessment of In-Stent Restenosis in Saphenous Vein Grafts
Q93192994Intravascular Ultrasound Pulmonary Artery Denervation to Treat Pulmonary Arterial Hypertension (TROPHY1): Multicenter, Early Feasibility Study
Q93391094Intravascular ultrasound analysis of intraplaque versus subintimal tracking in percutaneous intervention for coronary chronic total occlusions: One year outcomes
Q54286701Intravenous Adenosine-Based Fractional Flow Reserve in Pre-TAVR Assessment of Severe AS: Finally Some Clarity?
Q46000107Ionic low-osmolar versus nonionic iso-osmolar contrast media to obviate worsening nephropathy after angioplasty in chronic renal failure patients: the ICON (Ionic versus non-ionic Contrast to Obviate worsening Nephropathy after angioplasty in chroni
Q58089587Is There Any Current Role for Bare-Metal Coronary Stents?
Q40996236Is There an Ideal Level of Platelet P2Y12-Receptor Inhibition in Patients Undergoing Percutaneous Coronary Intervention?: "Window" Analysis From the ADAPT-DES Study (Assessment of Dual AntiPlatelet Therapy With Drug-Eluting Stents).
Q31110506Is multivessel intervention in ST-elevation myocardial infarction associated with early harm? Insights from observational data.
Q40783276Is routine post-procedural anticoagulation warranted after primary percutaneous coronary intervention in ST-segment elevation myocardial infarction? Insights from the HORIZONS-AMI trial
Q51752013Ischemic outcomes after coronary intervention of calcified vessels in acute coronary syndromes. Pooled analysis from the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) and ACUITY (Acute Catheteri
Q38436521Lack of association between dual antiplatelet therapy use and stent thrombosis between 1 and 12 months following resolute zotarolimus-eluting stent implantation
Q43175072Late safety, efficacy, and cost-effectiveness of a zotarolimus-eluting stent compared with a paclitaxel-eluting stent in patients with de novo coronary lesions: 2-year follow-up from the ENDEAVOR IV trial (Randomized, Controlled Trial of the Medtron
Q93138887Left Main Chronic Total Occlusion Percutaneous Coronary Intervention: A Case Series
Q50117117Left Main Revascularization in 2017: Coronary Artery Bypass Grafting or Percutaneous Coronary Intervention?
Q91738643Left Ventricular Hypertrophy Does Not Affect 1-Year Clinical Outcomes in Patients Undergoing Transcatheter Aortic Valve Replacement
Q91591141Left Ventricular Unloading During Extracorporeal Membrane Oxygenation in Patients With Cardiogenic Shock
Q91141931Leveraging the Power of Marginal Gains to Improve Outcomes in Interventional Cardiology
Q91834766Long-Term Outcomes After Revascularization for Stable Ischemic Heart Disease: An Individual Patient-Level Pooled Analysis of 19 Randomized Coronary Stent Trials
Q91845561Long-term (5-year) clinical evaluation of the Resolute zotarolimus-eluting coronary stent: The RESOLUTE US clinical trial
Q46218015Long-term clinical outcomes in patients treated with drug-eluting compared to bare-metal stents for the treatment of transplant coronary artery disease
Q46738497Long-term outcomes after percutaneous coronary intervention of left main coronary artery for treatment of cardiac allograft vasculopathy after orthotopic heart transplantation
Q37491997Long-term outcomes of heart transplantation recipients with transplant coronary artery disease who develop in-stent restenosis after percutaneous coronary intervention.
Q92084494Management of Acute Myocardial Infarction During the COVID-19 Pandemic
Q93208447Management of Acute Myocardial Infarction During the COVID-19 Pandemic
Q96295354Management of Percutaneous Coronary Intervention Complications: Algorithms From the 2018 and 2019 Seattle Percutaneous Coronary Intervention Complications Conference
Q38179176Management of multivessel coronary artery disease
Q52371100Mechanical Circulatory Support in Chronic Total Occlusion Percutaneous Coronary Intervention: Insights From a Multicenter U.S. Registry.
Q51729965Mechanisms and Patterns of Intravascular Ultrasound In-Stent Restenosis Among Bare Metal Stents and First- and Second-Generation Drug-Eluting Stents.
Q89713117Mechanisms of Orbital Versus Rotational Atherectomy Plaque Modification in Severely Calcified Lesions Assessed by Optical Coherence Tomography
Q71361926Megacystis, microcolon, intestinal hypoperistalsis syndrome: possible pathogenesis
Q38373158Meta-analysis of trials on mortality after percutaneous coronary intervention compared with medical therapy in patients with stable coronary heart disease and objective evidence of myocardial ischemia
Q91982285Microcatheter-Protected Orbital Atherectomy for Severely Calcified Bifurcation Coronary Artery Disease With Single-Guiding Catheter Technique
Q38200070Minimizing femoral artery access complications during percutaneous coronary intervention: a comprehensive review
Q88285362Morphological Patterns of In-Stent Chronic Total Occlusions: An Intravascular Ultrasound Study
Q89968518Mortality after drug-eluting stents vs. coronary artery bypass grafting for left main coronary artery disease: a meta-analysis of randomized controlled trials
Q88613275Mortality risk after transcatheter aortic valve implantation: analysis of the predictive accuracy of the Transcatheter Valve Therapy registry risk assessment model
Q38896447Mortality, Length of Stay, and Cost Implications of Procedural Bleeding After Percutaneous Interventions Using Large-Bore Catheters
Q34383952Multicenter core laboratory comparison of the instantaneous wave-free ratio and resting Pd/Pa with fractional flow reserve: the RESOLVE study
Q37473327Mutational analysis of NM23-H2/NDP kinase identifies the structural domains critical to recognition of a c-myc regulatory element
Q50851482Neoatherosclerosis assessed with optical coherence tomography in restenotic bare metal and first- and second-generation drug-eluting stents.
Q43827461Nine-month angiographic and 2-year clinical follow-up of the NOYA biodegradable polymer sirolimus-eluting stent in the treatment of patients with de novo native coronary artery lesions: the NOYA I trial
Q38662878Novel Radiation Dose Reduction Fluoroscopic Technology Facilitates Chronic Total Occlusion Percutaneous Coronary Interventions.
Q48941781Novel minimally invasive surgical approach using an external ventricular assist device and extracorporeal membrane oxygenation in refractory cardiogenic shock
Q92967503Novel percutaneous dual-lumen cannula-based right ventricular assist device provides effective support for refractory right ventricular failure after left ventricular assist device implantation
Q82644877Novel use of the GuideLiner catheter to minimize contrast use during PCI in a patient with chronic kidney disease
Q57796509ORBITA
Q60925352OUTCOMES WITH USE OF THE RETROGRADE APPROACH FOR CORONARY CHRONIC TOTAL OCCLUSION INTERVENTIONS IN A CONTEMPORARY MULTICENTER US REGISTRY
Q89440171One-Year Follow-up of the European Ambulance Acute Coronary Syndrome Angiography Trial
Q52699615Opiate use in the Cath Lab: A transatlantic divide and new focus of research.
Q44528998Optimizing rotational atherectomy in high-risk percutaneous coronary interventions: insights from the PROTECT ΙΙ study
Q47637154Orbital atherectomy for the treatment of severely calcified coronary lesions: evidence, technique, and best practices
Q53215061Outcomes After Successful Percutaneous Coronary Intervention of Calcified Lesions Using Rotational Atherectomy, Cutting-Balloon Angioplasty, or Balloon-Only Angioplasty Before Drug-Eluting Stent Implantation.
Q37015795Outcomes With the Use of the Retrograde Approach for Coronary Chronic Total Occlusion Interventions in a Contemporary Multicenter US Registry
Q95923880Outcomes of Patients Bridged with Acute Mechanical Circulatory Support Devices to HeartMate 3
Q36250548Outcomes of a Combined Approach of Percutaneous Coronary Revascularization and Cardiac Valve Surgery
Q91636281Outcomes of patients with right ventricular failure requiring short-term hemodynamic support with the Impella RP device
Q39171472Outcomes of stenting extra-small (≤2.25 mm) vessels using the Resolute zotarolimus-eluting stent (R-ZES).
Q38441489Outcomes of transcatheter and surgical aortic valve replacement in high-risk patients with aortic stenosis and left ventricular dysfunction: results from the Placement of Aortic Transcatheter Valves (PARTNER) trial (cohort A).
Q36154232Outcomes with various drug eluting or bare metal stents in patients with diabetes mellitus: mixed treatment comparison analysis of 22,844 patient years of follow-up from randomised trials.
Q60925364PREVALENCE, INDICATIONS AND MANAGEMENT OF BALLOON UNCROSSABLE CHRONIC TOTAL OCCLUSIONS: INSIGHTS FROM A CONTEMPORARY MULTICENTER US REGISTRY
Q47908774Paclitaxel-eluting coronary stents in patients with diabetes mellitus: pooled analysis from 5 randomized trials
Q37031505Patient radiation exposure during transcatheter aortic valve replacement procedures
Q38107887Patients who require non-cardiac surgery in acute coronary syndrome
Q38777195Percutaneous Coronary Intervention With Bioresorbable Scaffolds in a Young Child.
Q38376910Percutaneous Coronary Intervention of Saphenous Vein Graft
Q47711302Percutaneous coronary intervention of bifurcation lesions and platelet reactivity
Q49972170Percutaneous coronary intervention of lesions with in-stent restenosis: A report from the ADAPT-DES study
Q94456575Performance of Hospitals When Assessing Disease-Based Mortality Compared With Procedural Mortality for Patients With Acute Myocardial Infarction
Q53253517Performance of currently available risk models in a cohort of mechanically supported high-risk percutaneous coronary intervention--From the PROTECT II randomized trial.
Q96028621Pharmacological Agents Targeting Thromboinflammation in COVID-19: Review and Implications for Future Research
Q64103444Physical Activity After Percutaneous Coronary Intervention for Chronic Total Occlusion and Its Association With Health Status
Q38379501Platelet Reactivity and Clinical Outcomes After Coronary Artery Implantation of Drug-Eluting Stents in Subjects With Peripheral Arterial Disease: Analysis From the ADAPT-DES Study (Assessment of Dual Antiplatelet Therapy With Drug-Eluting Stents).
Q89125284Platelet Reactivity and Risk of Ischemic Stroke After Coronary Drug-Eluting Stent Implantation: From the ADAPT-DES Study
Q38153573Platelet function and genetic testing.
Q41968141Platelet reactivity and clinical outcomes after coronary artery implantation of drug-eluting stents (ADAPT-DES): a prospective multicentre registry study
Q89679903Polymer-based or Polymer-free Stents in Patients at High Bleeding Risk
Q51364291Possible Subclinical Leaflet Thrombosis in Bioprosthetic Aortic Valves.
Q38433830Post-PCI Antithrombotic Therapy in Patients Requiring Long-Term Anticoagulation
Q85345619Postprocedural anticoagulation for specific therapeutic indications after revascularization for ST-segment elevation myocardial infarction (from the Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction Trial)
Q45066266Practice Patterns and In-Hospital Outcomes Associated With Bivalirudin Use Among Patients With Non-ST-Segment-Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention in the United States
Q38000673Practices and complications of vascular closure devices and manual compression in patients undergoing elective transfemoral coronary procedures
Q89733269Practicing Art in Clinical Medicine: Clinical Commentary on "It Happened So Fast... I Guess, Yes, I Was Lucky"
Q36407121Predictable and SuStainable Implementation of National Cardiovascular Registries (PASSION) infrastructure: A think tank report from Medical Device Epidemiological Network Initiative (MDEpiNet)
Q44264392Predicting paravalvular regurgitation following transcatheter valve replacement: utility of a novel method for three-dimensional echocardiographic measurements of the aortic annulus
Q57818728Prediction of Ischemic and Bleeding Events Using the Dual Antiplatelet Therapy Score in an Unrestricted Percutaneous Coronary Intervention Population
Q38128135Prediction of coronary risk by SYNTAX and derived scores: synergy between percutaneous coronary intervention with taxus and cardiac surgery
Q30366121Predictors and Long-Term Clinical Impact of Acute Stent Malapposition: An Assessment of Dual Antiplatelet Therapy With Drug-Eluting Stents (ADAPT-DES) Intravascular Ultrasound Substudy.
Q40346679Predictors of Excess Patient Radiation Exposure During Chronic Total Occlusion Coronary Intervention: Insights From a Contemporary Multicentre Registry.
Q57479596Predictors of Survival for Patients with Acute Decompensated Heart Failure Requiring Extra-Corporeal Membrane Oxygenation Therapy
Q34343316Predictors of poor outcomes after transcatheter aortic valve replacement: results from the PARTNER (Placement of Aortic Transcatheter Valve) trial.
Q47388957Predictors of survival and ability to wean from short-term mechanical circulatory support device following acute myocardial infarction complicated by cardiogenic shock.
Q88697147Pressure wire compared to microcatheter sensing for coronary fractional flow reserve: the PERFORM study
Q51222402Prevalence and Clinical Impact of Tissue Protrusion After Stent Implantation: An ADAPT-DES Intravascular Ultrasound Substudy.
Q57053154Prevalence and Outcomes of Percutaneous Coronary Interventions for Ostial Chronic Total Occlusions: Insights From a Multicenter Chronic Total Occlusion Registry
Q38410176Prevalence and impact of high platelet reactivity in chronic kidney disease: results from the Assessment of Dual Antiplatelet Therapy with Drug-Eluting Stents registry
Q38390273Prevalence, Features, and Prognostic Importance of Edge Dissection After Drug-Eluting Stent Implantation: An ADAPT-DES Intravascular Ultrasound Substudy
Q88888403Prevalence, predictors, and health status implications of periprocedural complications during coronary chronic total occlusion angioplasty
Q91738616Procedural Outcomes of Percutaneous Coronary Interventions for Chronic Total Occlusions Via the Radial Approach: Insights From an International Chronic Total Occlusion Registry
Q53665698Procedural variation in the performance of primary percutaneous coronary intervention for ST-elevation myocardial infarction: a SCAI-based survey study of US interventional cardiologists.
Q90647004Proceedings from the 3rd European Clinical Consensus Conference for clinical trials in device-based hypertension therapies
Q38475716Prognostic significance of elevated baseline troponin in patients with acute coronary syndromes and chronic kidney disease treated with different antithrombotic regimens: a substudy from the ACUITY trial
Q38413975Propensity-matched comparisons of clinical outcomes after transapical or transfemoral transcatheter aortic valve replacement: a placement of aortic transcatheter valves (PARTNER)-I trial substudy
Q64075566Prospective Comparison of a Percutaneous Ventricular Assist Device and Venoarterial Extracorporeal Membrane Oxygenation for Patients With Cardiogenic Shock Following Acute Myocardial Infarction
Q38402115Proton Pump Inhibitors, Platelet Reactivity, and Cardiovascular Outcomes After Drug-Eluting Stents in Clopidogrel-Treated Patients: The ADAPT-DES Study
Q40103494Quantifying Ischemic Risk After Percutaneous Coronary Intervention Attributable to High Platelet Reactivity on Clopidogrel (From the Assessment of Dual Antiplatelet Therapy with Drug-Eluting Stents Study).
Q90368128Quantitative flow ratio-guided strategy versus angiography-guided strategy for percutaneous coronary intervention: Rationale and design of the FAVOR III China trial
Q90044798RESPONSE: CHIP Training: Thinking Beyond the Numbers
Q50096167Race/Ethnicity-Based Outcomes in Cardiovascular Medicine
Q50154495Radial access in patients with ST-segment elevation myocardial infarction undergoing primary angioplasty in acute myocardial infarction: the HORIZONS-AMI trial
Q37587486Rat model of veno-arterial extracorporeal membrane oxygenation.
Q91462752Rationale and design of the EVOLVE Short DAPT Study to assess 3-month dual antiplatelet therapy in subjects at high risk for bleeding undergoing percutaneous coronary intervention
Q92773863Rationale and design of the Onyx ONE global randomized trial: A randomized controlled trial of high-bleeding risk patients after stent placement with 1 month of dual antiplatelet therapy
Q91919500Re-wire but don't necessarily kiss twice for bifurcations treated with two stents: The DR-crush technique
Q90832082Real world validation of the nonhyperemic index of coronary artery stenosis severity-Resting full-cycle ratio-RE-VALIDATE
Q44662878Rebuttal: "Closure of patent foramen ovale and prevention of recurrent thromboembolic events".
Q87235792Rebuttal: "a critical appraisal of a meta-analysis comparing transcatheter closure of PFO versus medical therapy"
Q95550667Redesigning Care for Patients With Acute Myocardial Infarction Complicated by Cardiogenic Shock: The "Shock Team"
Q40806431Relation Between Platelet Count and Platelet Reactivity to Thrombotic and Bleeding Risk: From the Assessment of Dual Antiplatelet Therapy With Drug-Eluting Stents Study
Q47954675Relation Between Renal Function and Coronary Plaque Morphology (from the Assessment of Dual Antiplatelet Therapy With Drug-Eluting Stents Virtual Histology-Intravascular Ultrasound Substudy).
Q46966155Relation between coronary calcium and major bleeding after percutaneous coronary intervention in acute coronary syndromes (from the Acute Catheterization and Urgent Intervention Triage Strategy and Harmonizing Outcomes With Revascularization and Ste
Q37100880Relation between six-minute walk test performance and outcomes after transcatheter aortic valve implantation (from the PARTNER trial)
Q92374627Relation of Postdischarge Care Fragmentation and Outcomes in Transcatheter Aortic Valve Implantation from the STS/ACC TVT Registry
Q35762964Relation of frailty to outcomes after transcatheter aortic valve replacement (from the PARTNER trial)
Q42644667Relation of impaired Thrombolysis In Myocardial Infarction myocardial perfusion grades to residual thrombus following the restoration of epicardial patency in ST-elevation myocardial infarction
Q90666866Relationship Between Intravascular Ultrasound Guidance and Clinical Outcomes After Drug-Eluting Stents
Q51507336Relationship Between Platelet Reactivity and Culprit Lesion Morphology: An Assessment From the ADAPT-DES Intravascular Ultrasound Substudy.
Q93168012Relationship Between Stent Diameter, Platelet Reactivity, and Thrombotic Events After Percutaneous Coronary Artery Revascularization
Q46754031Relationship between uncontrolled risk factors and C-reactive protein levels in patients receiving standard or intensive statin therapy for acute coronary syndromes in the PROVE IT-TIMI 22 trial
Q87307993Renal Denervation for the Treatment of Hypertension: Making a New Start, Getting It Right
Q53405590Renal Denervation for the Treatment of Hypertension: Making a New Start, Getting It Right.
Q42345826Renal denervation for the treatment of hypertension: If at first you don't succeed, try and try again
Q48453071Renal denervation for the treatment of hypertension: Making a new start, getting it right
Q89548528Reply: Characteristic Left Ventricular Regional Wall Motion Abnormality Can Help Prevent Unnecessary Ischemic Workup
Q48538195Reply: Clinical Significance of Intravascular Ultrasound-Detected Vascular Injury Following Chronic Total Occlusion Recanalization With Intraplaque Versus Subintimal Tracking Techniques
Q92729394Reply: Left Ventricle Unloading Strategy: Which One Is More Effective in Venoarterial Extracorporeal Membrane Oxygenation Patients?
Q53564995Reply: Routine Ischemic Work-Up for Patients With New-Onset Heart Failure.
Q51462278Response to Letter Regarding Article, "Proton Pump Inhibitors, Platelet Reactivity, and Cardiovascular Outcomes After Drug-Eluting Stents in Clopidogrel-Treated Patients: The ADAPT-DES Study".
Q93178488Restructuring Electrophysiology During the COVID-19 Pandemic: A Practical Guide from a New York City Hospital Network
Q50016158Retrograde CTO-PCI of Native Coronary Arteries Via Left Internal Mammary Artery Grafts: Insights From a Multicenter U.S. Registry
Q89815932Retrograde Chronic Total Occlusion Percutaneous Coronary Intervention via Saphenous Vein Graft
Q89370220Retrograde approach to an ostial left anterior descending chronic total occlusion through a left internal mammary artery graft
Q36888098Revascularization in heart failure: the role of percutaneous coronary intervention
Q37146054Revascularization of unprotected left main coronary artery disease with percutaneous coronary intervention: the role of drug-eluting stents.
Q47631740Role of Hospital Volumes in Identifying Low-Performing and High-Performing Aortic and Mitral Valve Surgical Centers in the United States.
Q41501280Role of enhanced Na+ entry in the control of Na,K-ATPase gene expression by serum
Q94678349SCAI Position Statement on Optimal Percutaneous Coronary Interventional Therapy for Complex Coronary Artery Disease
Q88163921STEMI care in China: a world opportunity
Q39764608Safety and Efficacy of Bivalirudin in Patients With Diabetes Mellitus Undergoing Percutaneous Coronary Intervention: From the REPLACE-2, ACUITY and HORIZONS-AMI Trials
Q91756914Safety and efficacy of bivalirudin monotherapy in patients with non-ST-segment elevation acute coronary syndromes with positive biomarkers undergoing percutaneous coronary intervention: a report from the Acute Catheterization and Urgent Intervention
Q53057713Safety and efficacy of drug-eluting and bare metal stents: comprehensive meta-analysis of randomized trials and observational studies.
Q50176817Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents
Q43967182Same-day discharge or overnight stay after percutaneous coronary intervention: comparison of net adverse cardiovascular events
Q37919637Saphenous vein graft intervention
Q85121343Selection criteria for drug-eluting versus bare-metal stents and the impact of routine angiographic follow-up: 2-year insights from the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) trial
Q80942033Sequential risk stratification using TIMI risk score and TIMI flow grade among patients treated with fibrinolytic therapy for ST-segment elevation acute myocardial infarction
Q46528607Serum blood urea nitrogen as an independent marker of subsequent mortality among patients with acute coronary syndromes and normal to mildly reduced glomerular filtration rates
Q90565806Severe coronary artery spasm presenting as Prinzmetal's angina following cardiac transplantation
Q38380899Sex Differences in the Clinical Impact of High Platelet Reactivity After Percutaneous Coronary Intervention With Drug-Eluting Stents: Results From the ADAPT-DES Study (Assessment of Dual Antiplatelet Therapy With Drug-Eluting Stents).
Q50229683Sex differences in the effect of diabetes mellitus on platelet reactivity and coronary thrombosis: From the Assessment of Dual Antiplatelet Therapy with Drug-Eluting Stents (ADAPT-DES) study
Q39978024Sex-Specific Differences at Presentation and Outcomes Among Patients Undergoing Transcatheter Aortic Valve Replacement: A Cohort Study
Q47557721Sex-Specific Outcomes of Transcatheter Aortic Valve Replacement With the SAPIEN 3 Valve: Insights From the PARTNER II S3 High-Risk and Intermediate-Risk Cohorts
Q51158696Sex-related differences in outcomes after transcatheter or surgical aortic valve replacement in patients with severe aortic stenosis: Insights from the PARTNER Trial (Placement of Aortic Transcatheter Valve).
Q92855940Sham-Controlled Randomized Trials of Catheter-Based Renal Denervation in Patients With Hypertension
Q36102874Sharing Data from Cardiovascular Clinical Trials--A Proposal
Q39434488Shedding blood: anemia and adverse events after percutaneous coronary intervention (PCI).
Q46834201Short- and long-term outcomes after stent-assisted percutaneous treatment of saphenous vein grafts in the drug-eluting stent era.
Q50149110Should We Up the Intensity of Statin Therapy After Placing a Drug-eluting Stent
Q87357717Should all stent patients have prolonged dual antiplatelet therapy?
Q92423092Six-Month Results of Treatment-Blinded Medication Titration for Hypertension Control Following Randomization to Endovascular Ultrasound Renal Denervation or a Sham Procedure in the RADIANCE-HTN SOLO Trial
Q44840220Stent thrombosis after successful sirolimus-eluting stent implantation
Q37996688Stent thrombosis with drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis.
Q38016250Stent thrombosis with everolimus-eluting stents: meta-analysis of comparative randomized controlled trials
Q89711644Stent-Related Adverse Events >1 Year After Percutaneous Coronary Intervention
Q52330465Stenting in Primary Percutaneous Coronary Intervention for Acute ST-Segment Elevation Myocardial Infarction.
Q37955347Stroke associated with surgical and transcatheter treatment of aortic stenosis: a comprehensive review
Q95926523Successful Use of Veno-Arterial Extracorporeal Membrane Oxygenation as a Bridging Strategy in INTERMACS 1 Patients Undergoing HeartMate 3 LVAD Implantation
Q38410814Surgical versus percutaneous coronary revascularization for multivessel disease in diabetic patients with non-ST-segment-elevation acute coronary syndrome: analysis from the Acute Catheterization and Early Intervention Triage Strategy trial
Q40227677Synergistic relationship between hyperglycaemia and inflammation with respect to clinical outcomes in non-ST-elevation acute coronary syndromes: analyses from OPUS-TIMI 16 and TACTICS-TIMI 18.
Q52630780Systematic review of efficacy and safety of retrievable inferior vena caval filters.
Q90955506TAVR After Prior Mitral Valve Surgery: Results from the Transcatheter Valve Therapy Registry
Q57458444TCT-308 Impact of Race and Ethnicity on Technical and In-Hospital Outcomes Following Chronic Total Occlusions Percutaneous Coronary Intervention
Q57741397TCT-674 Sex Specific Outcomes of TAVR with the Sapien 3 Valve: Insights From The PARTNER 2 S3 High-Risk and Intermediate-Risk Cohorts
Q57741401TCT-691 Sex-Specific Differences After Transcatheter or Surgical Aortic Valve Replacement in Intermediate Risk Patients: An Analysis from the PARTNER 2 Randomized Trial
Q88644359Temporal Trends and Factors Associated With Prolonged Length of Stay in Patients With ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
Q90542450Temporal Trends in Chronic Total Occlusion Percutaneous Coronary Interventions: Insights From the PROGRESS-CTO Registry
Q36673541Temporal Trends in Quality of Life Outcomes After Transapical Transcatheter Aortic Valve Replacement: A Placement of AoRTic TraNscathetER Valve (PARTNER) Trial Substudy.
Q81415387Temporal changes in TIMI myocardial perfusion grade in relation to epicardial flow, ST-resolution and left ventricular function after primary percutaneous coronary intervention
Q51796471Temporal variability in the antiplatelet effects of clopidogrel and aspirin after elective drug-eluting stent implantation. An ADAPT-DES substudy.
Q46358602The "final" 5-year follow-up from the ENDEAVOR IV trial comparing a zotarolimus-eluting stent with a paclitaxel-eluting stent
Q51003816The Anchor-Tornus technique: a novel approach to "uncrossable" chronic total occlusions.
Q88138564The Changing Paradigm for Assessment of Ischemic Coronary Artery Disease
Q48047251The Complicated Calculus of Publicly Reporting Mortality After Percutaneous Coronary Intervention
Q92886517The Effect and Relationship of Frailty Indices on Survival After Transcatheter Aortic Valve Replacement
Q88506448The Hybrid Approach to Chronic Total Occlusion Percutaneous Coronary Intervention: Update From the PROGRESS CTO Registry
Q50952167The Impact of Age and Sex on In-Hospital Outcomes of Chronic Total Occlusion Percutaneous Coronary Intervention.
Q92037188The Impact of Peripheral Artery Disease in Chronic Total Occlusion Percutaneous Coronary Intervention (Insights From PROGRESS-CTO Registry)
Q50608613The Impact of Proximal Vessel Tortuosity on the Outcomes of Chronic Total Occlusion Percutaneous Coronary Intervention: Insights From a Contemporary Multicenter Registry.
Q45935378The Impact of Timing of Ischemic and Hemorrhagic Events on Mortality After Percutaneous Coronary Intervention: The ADAPT-DES Study.
Q91861735The Importance of Listening to Patients: The Seattle Angina Questionnaire
Q53554372The Importance of Long-term Follow-up Within Randomized Clinical Trials of Cardiovascular Devices.
Q38021687The Placement of Aortic Transcatheter Valve (PARTNER) trial: clinical trialist perspective
Q89815920The REDUCE HTN: REINFORCE: Randomized, Sham-Controlled Trial of Bipolar Radiofrequency Renal Denervation for the Treatment of Hypertension
Q91828155The Restructuring of Structural Heart Disease Practice During The Covid-19 Pandemic
Q48901653The SYNTAX Score Does Not Predict Risk of Adverse Events in Patients With Non-ST Elevation Acute Coronary Syndrome Who Undergo Coronary Artery Bypass Graft Surgery
Q91648257The Use of AngioVac Thrombectomy in IVC Filter-Associated IVC Thrombosis
Q91531355The Variety of Cardiovascular Presentations of COVID-19
Q95623283The association between the extent of coronary artery disease and major bleeding events after percutaneous coronary intervention: from the ACUITY trial
Q85564776The benefit of ischemia-based revascularization for stable ischemic heart disease: the impact of FAME 2
Q87322399The end of ENDEAVOR IV: the stent comparison trial's final follow-up
Q24596908The impact of frailty status on survival after transcatheter aortic valve replacement in older adults with severe aortic stenosis: a single-center experience
Q49819909The influence of advanced age on venous-arterial extracorporeal membrane oxygenation outcomes
Q87154235The quickening path ahead for renal denervation therapies?
Q30458103The relative performance characteristics of the logistic European System for Cardiac Operative Risk Evaluation score and the Society of Thoracic Surgeons score in the Placement of Aortic Transcatheter Valves trial
Q85502738The utility of a 5-in-6 double catheter technique in treating complex coronary lesions via transradial approach: the DOCA-TRI study
Q49791362Thirty-Day Readmission Rate and Costs After Percutaneous Coronary Intervention in the United States: A National Readmission Database Analysis
Q41523087Transapical and Transaortic Transcatheter Aortic Valve Replacement in the United States
Q44259433Transapical aortic valve replacement for severe aortic stenosis: results from the nonrandomized continued access cohort of the PARTNER trial
Q91616328Transcatheter Cardiovascular Therapeutics 2018
Q38417819Transcatheter aortic valve replacement and standard therapy in inoperable patients with aortic stenosis and low EF.
Q37656312Transcatheter versus surgical aortic valve replacement in patients with diabetes and severe aortic stenosis at high risk for surgery: an analysis of the PARTNER Trial (Placement of Aortic Transcatheter Valve).
Q38835461Treatment of Higher-Risk Patients With an Indication for Revascularization: Evolution Within the Field of Contemporary Percutaneous Coronary Intervention
Q53201137Trends in Complications and Outcomes of Patients Undergoing Transfemoral Transcatheter Aortic Valve Replacement: Experience From the PARTNER Continued Access Registry.
Q92884998Trends in Usage and Clinical Outcomes of Coronary Atherectomy: A Report From the National Cardiovascular Data Registry CathPCI Registry
Q46404723Triage of patients with acute chest pain and possible cardiac ischemia: the elusive search for diagnostic perfection
Q50979607Two-year outcomes after percutaneous coronary intervention of calcified lesions with drug-eluting stents.
Q46578828U-shaped relationship of blood glucose with adverse outcomes among patients with ST-segment elevation myocardial infarction
Q92069313Ultra-low-contrast angiography in patients with advanced chronic kidney disease and previous coronary artery bypass surgery
Q88018530Underutilization of Coronary Artery Disease Testing Among Patients Hospitalized With New-Onset Heart Failure
Q34644302Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document
Q87396274Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document
Q87410383Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document
Q95423935Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document
Q38048557Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document (VARC-2).
Q86850189Updates to the ACCF/AHA and ESC STEMI and NSTEMI guidelines: putting guidelines into clinical practice
Q93175641Upstream Impact of Public Reporting
Q91849893Uptake of Drug-Eluting Bioresorbable Vascular Scaffolds in Clinical Practice: An NCDR Registry to Practice Project
Q39192624Use and Effectiveness of Bivalirudin Versus Unfractionated Heparin for Percutaneous Coronary Intervention Among Patients With ST-Segment Elevation Myocardial Infarction in the United States
Q37240474Use of Intravascular Imaging During Chronic Total Occlusion Percutaneous Coronary Intervention: Insights From a Contemporary Multicenter Registry.
Q36889216Use of antegrade dissection re-entry in coronary chronic total occlusion percutaneous coronary intervention in a contemporary multicenter registry
Q91864702Usefulness of Atherectomy in Chronic Total Occlusion Interventions (from the PROGRESS-CTO Registry)
Q53020656Utility of near-infrared spectroscopy for detection of thin-cap neoatherosclerosis.
Q47976208Validation Study of Image-Based Fractional Flow Reserve During Coronary Angiography
Q38434888Validation of residual SYNTAX score with second-generation drug-eluting stents: one-year results from the prospective multicentre SEEDS study
Q46115333Value of drug-eluting stents in cardiac transplant recipients
Q51768641Variability in maximal suggested door-in-door-out time for hospitals transferring patients for primary angioplasty in STEMI.
Q57176688Variation in post-TAVR antiplatelet therapy utilization and associated outcomes: Insights from the STS/ACC TVT Registry
Q36842487Vascular endothelial growth factors in pulmonary edema: an update.
Q92183909When Can Strut Thickness Really Matter in Percutaneous Coronary Intervention?
Q82328436When is better not good enough?: Insights from the COURAGE economic study
Q40955307Which Intraprocedural Thrombotic Events Impact Clinical Outcomes After Percutaneous Coronary Intervention in Acute Coronary Syndromes?: A Pooled Analysis of the HORIZONS-AMI and ACUITY Trials

Search more.